{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Zibotentan",
  "nciThesaurus": {
    "casRegistry": "186497-07-4",
    "chebiId": "",
    "chemicalFormula": "C19H16N6O4S",
    "definition": "An orally available selective antagonist of the endothelin-A (ET-A) receptor with potential antineoplastic activity. Zibotentan binds selectively to the ET-A receptor, thereby inhibiting endothelin-mediated mechanisms that promote tumor cell proliferation.",
    "fdaUniiCode": "8054MM4902",
    "identifier": "C48430",
    "preferredName": "Zibotentan",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C28313"
    ],
    "synonyms": [
      "3-Pyridinesulfonamide, N-(3-methoxy-5-methylpyrazinyl)-2-(4-(1,3,4-oxadiazol-2-yl)phenyl)-",
      "N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pridine-3- sulfonamide",
      "ZD-4054",
      "ZD4054",
      "ZIBOTENTAN",
      "Zibotentan"
    ]
  }
}